ALX ONCOLOGY HOLDINGS INC Capital Expenditures Incurred but Not yet Paid
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Capital Expenditures Incurred but Not yet Paid of $1.38 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2023-11-13
- 2023-09-30: Capital Expenditures Incurred but Not yet Paid 9 month $1.38M.
- 2022-09-30: Capital Expenditures Incurred but Not yet Paid 9 month $876.00K.
- 2020-06-30: Capital Expenditures Incurred but Not yet Paid 6 month $1.95M.
| Period end | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month |
|---|---|---|
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $876.00K 10-Q · filed 2023-11-13 | |
| 2020-06-30 | $1.95M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |